3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Interventions
Cisplatin
17
pembrolizumab
12
Radiotherapy
11
Nivolumab
7
Cetuximab
6
Paclitaxel
5
fludarabine
4
aldesleukin
4
Radiation
4
Interleukin-2
4
Docetaxel
4
Cyclophosphamide
4
olaparib
3
fludarabine phosphate
3
Carboplatin
3
talimogene laherparepvec
2
atezolizumab
2
Taxes
2
Sorafenib
2
Fluorouracil
2
Erlotinib Hydrochloride
2
Drug Therapy
2
Capecitabine
2
Bortezomib
2
130-nm albumin-bound paclitaxel
2
vandetanib
1
tozuleristide
1
tilsotolimod
1
testosterone enanthate
1
temoporfin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Carcinoma, Squamous Cell
×
Hyperbaric Oxygenation
×
Clear all
NCT00474825
2012-02-06
HBO-XRT
National Baromedical Services
Phase 1
Completed
12 enrolled